You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: July 25, 2024

SUMAVEL DOSEPRO Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Sumavel Dosepro patents expire, and when can generic versions of Sumavel Dosepro launch?

Sumavel Dosepro is a drug marketed by Endo Ventures Ltd and is included in one NDA. There are three patents protecting this drug.

This drug has fourteen patent family members in eight countries.

The generic ingredient in SUMAVEL DOSEPRO is sumatriptan succinate. There are twenty-four drug master file entries for this compound. Thirty-two suppliers are listed for this compound. Additional details are available on the sumatriptan succinate profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Sumavel Dosepro

A generic version of SUMAVEL DOSEPRO was approved as sumatriptan succinate by WEST-WARD PHARMS INT on February 6th, 2009.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for SUMAVEL DOSEPRO?
  • What are the global sales for SUMAVEL DOSEPRO?
  • What is Average Wholesale Price for SUMAVEL DOSEPRO?
Summary for SUMAVEL DOSEPRO
Drug patent expirations by year for SUMAVEL DOSEPRO
Drug Prices for SUMAVEL DOSEPRO

See drug prices for SUMAVEL DOSEPRO

Recent Clinical Trials for SUMAVEL DOSEPRO

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Synteract, Inc.Phase 4
Zogenix, Inc.Phase 4

See all SUMAVEL DOSEPRO clinical trials

US Patents and Regulatory Information for SUMAVEL DOSEPRO

SUMAVEL DOSEPRO is protected by three US patents.

Patents protecting SUMAVEL DOSEPRO

Device for readying a needle free injector for delivery
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up

Casing
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up

Device for readying a needle free injector for delivery
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Endo Ventures Ltd SUMAVEL DOSEPRO sumatriptan succinate INJECTABLE;SUBCUTANEOUS 022239-002 Nov 26, 2013 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Endo Ventures Ltd SUMAVEL DOSEPRO sumatriptan succinate INJECTABLE;SUBCUTANEOUS 022239-001 Jul 15, 2009 DISCN Yes No ⤷  Sign Up ⤷  Sign Up Y ⤷  Sign Up
Endo Ventures Ltd SUMAVEL DOSEPRO sumatriptan succinate INJECTABLE;SUBCUTANEOUS 022239-001 Jul 15, 2009 DISCN Yes No ⤷  Sign Up ⤷  Sign Up Y ⤷  Sign Up
Endo Ventures Ltd SUMAVEL DOSEPRO sumatriptan succinate INJECTABLE;SUBCUTANEOUS 022239-001 Jul 15, 2009 DISCN Yes No ⤷  Sign Up ⤷  Sign Up Y ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for SUMAVEL DOSEPRO

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Endo Ventures Ltd SUMAVEL DOSEPRO sumatriptan succinate INJECTABLE;SUBCUTANEOUS 022239-001 Jul 15, 2009 ⤷  Sign Up ⤷  Sign Up
Endo Ventures Ltd SUMAVEL DOSEPRO sumatriptan succinate INJECTABLE;SUBCUTANEOUS 022239-001 Jul 15, 2009 ⤷  Sign Up ⤷  Sign Up
Endo Ventures Ltd SUMAVEL DOSEPRO sumatriptan succinate INJECTABLE;SUBCUTANEOUS 022239-001 Jul 15, 2009 ⤷  Sign Up ⤷  Sign Up
Endo Ventures Ltd SUMAVEL DOSEPRO sumatriptan succinate INJECTABLE;SUBCUTANEOUS 022239-001 Jul 15, 2009 ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

International Patents for SUMAVEL DOSEPRO

See the table below for patents covering SUMAVEL DOSEPRO around the world.

Country Patent Number Title Estimated Expiration
European Patent Office 1439872 INJECTEUR SANS AIGUILLE EQUIPE D'UN COMPOSANT AMORTISSEUR SITUE ENTRE LE POUSSOIR ET LE PISTON (NEEDLELESS INJECTOR WITH SHOCK ABSORBING MEANS BETWEEN RAM AND PISTON) ⤷  Sign Up
Russian Federation 2161511 DISTRIBUTION DEVICE WITH SPRING DRIVE ⤷  Sign Up
Russian Federation 2155609 FILLING DEVICE FOR JET INJECTOR CONTAINER ⤷  Sign Up
Canada 2207991 DISPOSITIF DE REMPLISSAGE POUR CARTOUCHE D'INJECTEUR SANS AIGUILLE (FILLING DEVICE FOR A NEEDLELESS INJECTOR CARTRIDGE) ⤷  Sign Up
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.